GLAND PHARMA LTD
GenericsGLAND PHARMA LTD is a generic drug manufacturer focused on Cardiovascular, Infectious Disease, Respiratory.
GLAND PHARMA LTD's Key Drugs
GLAND PHARMA LTD's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
GLAND PHARMA LTD's Recent FDA Approvals
New NDA/BLA approvals for GLAND PHARMA LTD over the last two years — novel drugs only, excluding generics and label supplements.
GLAND PHARMA LTD's Therapeutic Areas
GLAND PHARMA LTD's approved drugs and pipeline span 5 therapeutic areas, led by Cardiovascular and Infectious Disease, across 0 biologic and 0 small-molecule drugs. Weighted by commercial stage — approved drugs count most, then late-stage trials.
GLAND PHARMA LTD's Top Competitors
GLAND PHARMA LTD's closest competitors by therapeutic-area and drug-target overlap include APOTHECON, Merck, and Baxter. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
GLAND PHARMA LTD Pipeline Snapshot
Active clinical trials for GLAND PHARMA LTD across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Cardiovascular pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2004-07-27
- Latest
- 2025-11-17
- Applications
- 17